Stay updated on Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the study page, with no observable changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:16:51.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Removal of the funding status notice about government operating status and potential processing delays.
    Difference
    0.4%
    Check dated 2025-11-17T18:42:10.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The study record shows termination due to slow enrollment and lack of efficacy, with results posted on 2022-10-20.
    Difference
    0.5%
    Check dated 2025-11-03T13:18:13.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Upgrade notice with updated operating status info and a version bump from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-06T02:17:30.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-28T23:26:16.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page version has been updated from v3.0.1 to v3.0.2. The non-critical 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T09:48:54.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page.